Literature DB >> 24960746

Proctocolectomy for persistent haematochezia in a patient with Cronkhite-Canada Syndrome.

N Wijekoon1, M Samarasinghe1, U Dalpatadu1, N Nuzair1, P Pratheepan1, D Samarasekera1.   

Abstract

Cronkhite-Canada syndrome is an extremely rare condition of gastrointestinal polyposis in which the main presenting features are diarrhoea and dysgeusia. The polyps in this condition are characteristically distributed throughout the entire gastrointestinal tract except the oesophagus, and these patients exhibit unique ectodermal abnormalities. Herein, we report a 50-year-old male who had recurrent episodes of severe haematochezia from the polyps in the colon. Further examination and investigations revealed a diagnosis of Cronkhite-Canada syndrome. Proctocolectomy was carried out for medically refractory haematochezia and the patient is asymptomatic at present. © JSCR.

Entities:  

Year:  2012        PMID: 24960746      PMCID: PMC3649645          DOI: 10.1093/jscr/2012.10.6

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


INTRODUCTION

Haematochezia in an adult raises significant concern among patients and physicians. Common causes of haematochezia in adults are diverticular disease, vascular ectasia, colitis (ischaemic, inflammatory or infectious), colonic neoplasia and anorectal conditions (1). Haematochezia is not reported as a common mode of presentation among patients with Cronkhite-Canada syndrome (CCS) in which diarrhea and dysgeusia are the predominant initial presentations (2). Surgery in patients with CCS has been carried out for associated gastrointestinal tract malignancies, intestinal obstruction and severe protein loosing enteropathy (3). We present a case of persistent severe haematochezia in a patient with CCS, successfully managed with Proctocolectomy.

CASE REPORT

A 50-year-old Sri Lankan man presented with a 3-month history of diarrhoea, haematochezia and weight loss of 20kg. One month prior to these symptoms he has noticed dark pigmentation of the skin and hair loss. Physical examination revealed a cachectic man with alopecia, generalized skin hyperpigmentation involving the palms and onychodystrophy of fingernails (Fig 1–4).
Fig. 1

Alopecia

Alopecia Diffuse skin hyperpigmentation involving the palms Biochemical investigations revealed a haemoglobin value of 9g/dl and marked hypoalbuminaemia with serum albumin of 12g/l (normal- 36-44g/l). Upper gastrointestinal endoscopy and colonoscopy revealed multiple, sessile polyps of varying sizes distributed throughout the stomach, duodenum, colon and rectum without any polyps in the oesophagus. Video capsule endoscopy revealed numerous similar polyps throughout the small intestine (Fig 4). Onychodystrophy of finger nails Biopsy of colonic polyps revealed cystic dilatation of crypts with oedema of the lamina propria suggesting hamartomatous polyps. Thus, a diagnosis of Cronkhite-Canada syndrome was made, considering the characteristic ectodermal abnormalities on physical examination, endoscopic findings and histology. The patient was commenced on oral Prednisolone 40mg daily and oral Zinc supplements. Haematochezia worsened despite medical treatment for 2 months and proctocolectomy with a permanent ileostomy was performed. Histology of the specimen revealed multiple polyps with a diverse spectrum of morphologic features including juvenile-type polyps, adenomatous polyps, serrated adenomas, hamartomatous polyps and mixed polyps.

DISCUSSION

First described in 1955, Cronkhite-Canada syndrome (CCS) is a rare, nonhereditary polyposis syndrome with an uncertain aetiopathogenesis. Approximately about 400 cases have been reported in the literature with the majority being reported from Japan. It is characterized by the presence of diffuse gastrointestinal polyposis (sparing the oesophagus) associated with characteristic ectodermal abnormalities such as alopecia, nail dystrophy and cutaneous hyperpigmentation (4,5). The aetiology of CCS is currently unknown. Associations with raised ANA and IgG4 levels, hypothyroidism and various autoimmune diseases such as systemic lupus erythematous, rheumatoid arthritis and scleroderma have been published in the literature (6). Most of these patients present with diarrhea and dysgeusia and the dermatological manifestations are known to appear later (2). The presentation in our patient is different because he had not developed dysgeusia, his cutaneous symptoms have preceded the onset of diarrhoea and haematochezia was one of his key presenting features. There is no optimal treatment recommended for these patients. Up to now, different treatment modalities have been attempted with varying degrees of success (7). These include hyperalimentation, corticosteroids, H2-receptor antagonists, antibiotics, acid suppression, Cromolyn Sodium, anabolic steroids, surgery, and combinations of these therapies (7). Among the various complications reported, the risk of developing gastrointestinal malignancies is significant. This can be as high as 15% and both gastric and colorectal malignancies are known to occur in these patients (8,9). The long-term outcome of CCS is poor. Some studies have shown overall mortality rates as high as 55% among their patients (2). To our knowledge, this is the first case of total proctocolectomy for refractory haematochezia in a patient with CCS. This also highlights the importance of considering Cronkhite-Canada syndrome as a rare possibility in a middle aged male presenting with haematochezia, specially if the patient is of Asian origin and if there are any cutaneous abnormalities suggestive of this condition.
  9 in total

Review 1.  Pharmacological management of Cronkhite-Canada syndrome.

Authors:  Eric M Ward; Herbert C Wolfsen
Journal:  Expert Opin Pharmacother       Date:  2003-03       Impact factor: 3.889

2.  Generalized gastrointestinal polyposis; an unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia.

Authors:  L W CRONKHITE; W J CANADA
Journal:  N Engl J Med       Date:  1955-06-16       Impact factor: 91.245

3.  A case of cronkhite-Canada syndrome and a review of gastrointestinal polyposis syndromes.

Authors:  Deepti Seshadri; Nikolaos Karagiorgos; Matthew J Hyser
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-03

4.  Cronkhite-Canada syndrome.

Authors:  Smadar Samoha; Nadir Arber
Journal:  Digestion       Date:  2005-05-20       Impact factor: 3.216

Review 5.  Epidemiology of lower gastrointestinal bleeding.

Authors:  Gregory Zuccaro
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

6.  Corticosteroid-responsive Cronkhite-Canada syndrome complicated by thrombosis.

Authors:  Joanna E Sampson; Maureen L Harmon; Mary Cushman; Edward L Krawitt
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

7.  Surgical treatment of Cronkhite-Canada syndrome associated with protein-losing enteropathy: report of a case.

Authors:  M Hanzawa; N Yoshikawa; T Tezuka; K Konishi; K Kaneko; Y Akita; K Mitamura; A Tsunoda; M Takada; M Kusano
Journal:  Dis Colon Rectum       Date:  1998-07       Impact factor: 4.585

8.  The Cronkhite-Canada Syndrome. An analysis of clinical and pathologic features and therapy in 55 patients.

Authors:  E S Daniel; S L Ludwig; K J Lewin; R M Ruprecht; G M Rajacich; A D Schwabe
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

9.  Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions.

Authors:  Masakazu Yashiro; Hikaru Kobayashi; Naoshi Kubo; Yukio Nishiguchi; Kenichi Wakasa; Kosei Hirakawa
Journal:  Digestion       Date:  2004-01-30       Impact factor: 3.216

  9 in total
  2 in total

Review 1.  Cronkhite-Canada syndrome: a rare case report and literature review.

Authors:  Ruifeng Zhao; Mely Huang; Omar Banafea; Jinfang Zhao; Ling Cheng; Kaifang Zou; Liangru Zhu
Journal:  BMC Gastroenterol       Date:  2016-02-25       Impact factor: 3.067

2.  Effectiveness of cyclosporine as a treatment for steroid-resistant Cronkhite-Canada syndrome; two case reports.

Authors:  Kohei Yamakawa; Takuya Yoshino; Kotaro Watanabe; Koichiro Kawano; Akira Kurita; Naomi Matsuzaki; Yoshiaki Yuba; Shujiro Yazumi
Journal:  BMC Gastroenterol       Date:  2016-10-06       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.